Iovance Biotherapeutics Announces Breakthrough Therapy Designation for LN-145 for Treatment of Advanced Cervical Cancer Patients Who Have Progressed on or After Chemotherapy - Associated Press https://t.co/EeONAqcfHn
— IDRO (@IDROOhio) May 22, 2019
from Twitter https://twitter.com/IDROOhio
May 22, 2019 at 12:27PM
No comments:
Post a Comment